ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 950,17
0,11%
Dow Jones
44 719,73
-0,36%
DAX
21 732,05
0,01%
Brent Oil
76,26
0,28%
Bitcoin
103 000,00
-1,66%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSX

  6. COSCIENS Biopharma Inc (CSCI) Cours

COSCIENS Biopharma Inc

COSCIENS Biopharma Inc (CSCI)

COSCIENS Biopharma Inc
3,90
-0,10
( -2,50% )
Mis à jour : 19:34:11
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
3,90
Prix Achat
3,91
Prix Vente
4,03
Volume échangé
700
3,90 Fourchette du Jour 3,92
3,55 Plage de 52 semaines 9,00
Cap du marché
18,938M
Clôture Veille
4,00
Ouverture
3,92
Dernière Transaction
500
@
3.9
Dernière heure de transaction
19:16:40
Volume financier
-
VWAP
-
Volume moyen (3 m)
2 422
Actions en circulation
4 856 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,14
Bénéfice par action (BPA)
-3,41
Chiffre d'affairess
4,5M
Bénéfice net
-16,55M

À propos de COSCIENS Biopharma Inc

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.zentaris.com/
Siège social
Toronto, Ontario, Can
Fondé
-
COSCIENS Biopharma Inc est coté dans le secteur Pharmaceutical Preparations de la Toronto Stock Exchange avec le ticker CSCI. Le dernier cours de clôture d'COSCIENS Biopharma était de $4,00. Au cours de la dernière année, les actions de COSCIENS Biopharma ont été négociées dans une fourchette de prix de $ 3,55 à $ 9,00.

COSCIENS Biopharma compte actuellement 4 856 000 actions en circulation. La capitalisation boursière d'COSCIENS Biopharma est de $19,42 million. COSCIENS Biopharma a un ratio cours/bénéfice (ratio PE) de -1.14.

CSCI Dernières nouvelles

Plus de nouvelles

COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization

Company leveraging core competencies to develop and commercialize natural-based products to improve health and wellness Streamlined efficiencies and cost cutting measures taken to refine...

23 Décembre 2024
GlobeNewswire Inc.

COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs

Continued execution on merger integration with Ceapro Inc. and advancements across business Company ended the quarter with US$20.0 million in cash TORONTO, ONTARIO, Nov. 12, 2024 (GLOBE...

12 Novembre 2024
GlobeNewswire Inc.

COSCIENS Biopharma Announces Change to Board of Directors

TORONTO, ONTARIO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company developing and...

08 Octobre 2024
GlobeNewswire Inc.

COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director

TORONTO, ONTARIO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company developing and...

01 Octobre 2024
GlobeNewswire Inc.

COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs

TORONTO, ONTARIO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company developing and...

23 Septembre 2024
GlobeNewswire Inc.

COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

- Top-line data with unexpected results requiring further clarification, did not meet primary endpoint as per protocol - Potent growth hormone release following macimorelin stimulation - Safety of...

27 Août 2024
GlobeNewswire Inc.

COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results

                Data from pivotal DETECT-Trial evaluating macimorelin for the diagnosis of childhood-onset growth hormone deficiency expected in Q3 2024 Company ended the quarter with US$27.8...

13 Août 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.2-4.878048780494.14.153.5522363.8705654CS
4-0.27-6.474820143884.175.193.5518974.39699692CS
12-0.91-18.91891891894.815.193.5524224.1845166CS
26-4.5-53.57142857148.493.5519274.72293337CS
52-4.5-53.57142857148.493.5519274.72293337CS
156-4.5-53.57142857148.493.5519274.72293337CS
260-4.5-53.57142857148.493.5519274.72293337CS

CSCI - Frequently Asked Questions (FAQ)

What is the current COSCIENS Biopharma share price?
The current share price of COSCIENS Biopharma is $ 3,90
How many COSCIENS Biopharma shares are in issue?
COSCIENS Biopharma has 4 856 000 shares in issue
What is the market cap of COSCIENS Biopharma?
The market capitalisation of COSCIENS Biopharma is CAD 19,42M
What is the 1 year trading range for COSCIENS Biopharma share price?
COSCIENS Biopharma has traded in the range of $ 3,55 to $ 9,00 during the past year
What is the PE ratio of COSCIENS Biopharma?
The price to earnings ratio of COSCIENS Biopharma is -1,14
What is the cash to sales ratio of COSCIENS Biopharma?
The cash to sales ratio of COSCIENS Biopharma is 4,21
What is the reporting currency for COSCIENS Biopharma?
COSCIENS Biopharma reports financial results in USD
What is the latest annual turnover for COSCIENS Biopharma?
The latest annual turnover of COSCIENS Biopharma is USD 4,5M
What is the latest annual profit for COSCIENS Biopharma?
The latest annual profit of COSCIENS Biopharma is USD -16,55M
What is the registered address of COSCIENS Biopharma?
The registered address for COSCIENS Biopharma is AETERNA ZENTARIS INC, 222 BAY STREET, SUITE 3000, TORONTO, ONTARIO, M5K 1E7
What is the COSCIENS Biopharma website address?
The website address for COSCIENS Biopharma is www.zentaris.com/
Which industry sector does COSCIENS Biopharma operate in?
COSCIENS Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ESMEuro Sun Mining Inc
$ 0,05
(42,86%)
671,7k
SCYScandium International Mining Corp
$ 0,03
(20,00%)
832,02k
APLIAppili Therapeutics Inc
$ 0,035
(16,67%)
3k
CLSCelestica Inc
$ 184,19
(11,11%)
119,67k
BSXBelo Sun Mining Corp
$ 0,27
(10,20%)
1,49M
RTGRTG Mining Inc
$ 0,02
(-33,33%)
5k
WLLWWillow Biosciences Inc
$ 0,02
(-20,00%)
718,59k
NVONovo Resources Corp
$ 0,085
(-10,53%)
96,14k
NEXTNextSource Materials Inc
$ 0,79
(-10,23%)
101,64k
FTFortune Minerals Limited
$ 0,045
(-10,00%)
204,24k
CNQCanadian Natural Resources Ltd
$ 45,02
(0,49%)
2,73M
FFFirst Mining Gold Corp
$ 0,135
(3,85%)
2,52M
CSCapstone Copper Corp
$ 8,24
(-2,02%)
2,51M
CVECenovus Energy Inc
$ 21,46
(-0,56%)
2,34M
ATHAthabasca Oil Corporation
$ 4,93
(0,20%)
2,32M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

TSX
CSCI
COSCIENS Biopharma
BIT
P1NHR3
BNP Paribas Issuance
BIT
I07906
Intesa Sanpaolo
BIT
S30618
Societe Generale Effekten
BIT
UC838Y
Unicredit Bank
BIT
I10475
IT0005616203 20250303 6.5
BIT
SS5NVD
Societe Generale Effekten
BIT
S30608
Societe Generale Effekten
BIT
P41211
BNP Paribas Issuance
BIT
1HPE
Hewlett Packard Enterprise
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces